References
1. Hammer MJ, Casper C, Gooley TA, O’Donnell PV, Boeckh M, Hirsch IB. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2009;15(3):344-351.
2. Storey S, Von Ah D. Impact of malglycemia on clinical outcomes in hospitalized patients with cancer: a review of the literature.Oncol Nurs Forum. 2012;39(5):458-465.
3. Sopfe J, Pyle L, Keating AK, et al. Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients. Blood Adv. 2019;3(3):350-359.
4. Rodbard D. The challenges of measuring glycemic variability.Journal of diabetes science and technology. 2012;6(3):712-715.
5. Monnier L, Colette C, Wojtusciszyn A, et al. Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.Diabetes Care. 2017;40(7):832-838.
6. Kovatchev B, Cobelli C. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes. Diabetes care.2016;39(4):502-510.
7. Danne T, Nimri R, Battelino T, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes care.2017;40(12):1631-1640.
8. Salkind SJ, Huizenga R, Fonda SJ, Walker MS, Vigersky RA. Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literature. J Diabetes Sci Technol. 2014;8(5):1042-1047.
9. MacMillan ML, Weisdorf DJ, Wagner JE, et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant.2002;8(7):387-394.
10. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.N Engl J Med. 1999;341(1):14-21.
11. Cetin M, Yetgin S, Kara A, et al. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia. J Med. 1994;25(3-4):219-229.
12. Yoshida H, Imamura T, Saito AM, et al. Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.PLoS One. 2015;10(8):e0136428.
13. Gatzioura I, Papakonstantinou E, Dimitriadou M, et al. Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer. 2016;63(7):1181-1184.
14. Petryk A, Kanakatti Shankar R, Giri N, et al. Endocrine disorders in Fanconi anemia: recommendations for screening and treatment. J Clin Endocrinol Metab. 2015;100(3):803-811.
15. Derr RL, Hsiao VC, Saudek CD. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care. 2008;31(10):1972-1977.
16. Fuji S, Kim SW, Mori S, et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.Transplantation. 2007;84(7):814-820.
17. Garg R, Bhutani H, Alyea E, Pendergrass M. Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation.Diabetes Care. 2007;30(4):993-994.
18. Pidala J, Kim J, Kharfan-Dabaja MA, et al. Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes. Biol Blood Marrow Transplant.2011;17(2):239-248.
19. Sheean P, Braunschweig C. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients. JPEN J Parenter Enteral Nutr. 2006;30(4):345-350.
20. de Souza Ferreira C, Araujo TH, Angelo ML, et al. Neutrophil dysfunction induced by hyperglycemia: modulation of myeloperoxidase activity. Cell Biochem Funct. 2012;30(7):604-610.
21. Gyurko R, Siqueira CC, Caldon N, Gao L, Kantarci A, Van Dyke TE. Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol.2006;177(10):7250-7256.
22. Fuji S, Rovo A, Ohashi K, et al. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.Bone Marrow Transplant. 2016.
23. Fuji S, Loffler J, Savani BN, Einsele H, Kapp M. Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52(5):657-662.
24. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-1687.
25. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52(11):2795-2804.
26. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab.2001;281(5):E924-930.
27. Stegenga ME, van der Crabben SN, Blumer RM, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.Blood. 2008;112(1):82-89.
28. Oldenborg PA, Sehlin J. Hyperglycemia in vitro attenuates insulin-stimulated chemokinesis in normal human neutrophils. Role of protein kinase C activation. J Leukoc Biol. 1999;65(5):635-640.
29. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia.Crit Care Clin. 2001;17(1):107-124.
30. Agus MS, Wypij D, Hirshberg EL, et al. Tight Glycemic Control in Critically Ill Children. The New England journal of medicine.2017;376(8):729-741.
31. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. The New England journal of medicine. 2009;360(13):1283-1297.
32. Investigators N-SS, Finfer S, Liu B, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med.2012;367(12):1108-1118.
33. Agus MS, Asaro LA, Steil GM, et al. Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial.Circulation. 2014;129(22):2297-2304.
34. De Block CE, Gios J, Verheyen N, et al. Randomized Evaluation of Glycemic Control in the Medical Intensive Care Unit Using Real-Time Continuous Glucose Monitoring (REGIMEN Trial). Diabetes Technol Ther. 2015;17(12):889-898.
35. Smith AR, Majhail NS, MacMillan ML, et al. Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients. Blood. 2011;117(9):2728-2734.